Erector Spinae Regional Anesthesia for Pain Control

The University of Texas System (UT)

Status and phase: Enrolling; Early Phase 1

Conditions: Pain Management

Treatments: Drug: Bupivacaine Injection

Study type: Interventional

Funder types: Other

Identifiers

NCT05794828

HSC20220911H

Details and patient eligibility

About

Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain for multimodal pain therapy to determine its assistance with pain relief as well as the patient's use of opiates after block completion

Full description

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance. They will rate their pain before and 30 minutes after the procedure using the ordinal categorical data on a numeric pain scale. Total patient opiate use will be gathered up to 8 hours after block completion.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Posterior/lateral rib or vertebral fractures
• Pancreatitis or pancreatic cancer
• Renal colic
• Back pain

Exclusion criteria

• Unstable vitals
• Infection or open wound over insertion site
• Prior allergic reaction to local anesthetic
• Pregnant females
• Patients <18 years old
• Altered mentation

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Erector Spinae Plane Block (ESP) administration

Experimental group

Description:

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance.

Treatment:

Drug: Bupivacaine Injection